Triveni

Series-B+
triveni.bio Biotech & Healthcare
Total Funding $65M
Latest Round $65M Series-B+
Last Announced Jun 17, 2026
Investors Undisclosed
Decision Makers 6 Verified

About Triveni

Develops antibody-based therapeutics for immune and inflammatory diseases.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Undisclosed
Tracked Since Sep 29, 2026

Web & Domain Identity

Official Website triveni.bio
Domain Registered Date Feb 7, 2023

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $65,000,000 · Series-B+

    fundraisingfox.com

  2. Milestone

    Website domain registered

    triveni.bio

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Triveni.

Funding History

1 Round
Series-B+ · Jun 17, 2026

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts